Marléne Isaksson

Dr. Marléne Isaksson


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2022 in Contact Dermatitis
Verified
Journal Article
Closed access
SWS. Mark Wilkinson
S. Mark Wilkinson
MGMargarida Gonçalo
Margarida Gonçalo
OAOlivier Aerts
Olivier Aerts
SBSonia Badulici
Sonia Badulici
HDHeinrich Dickel
Heinrich Dickel
Wolfgang UterWolfgang Uter
Wolfgang Uter

10 November 2005 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
MIMarléne Isaksson
Marléne Isaksson
MLMagnus Lindberg
Magnus Lindberg
KSKarin Sundberg
Karin Sundberg
AHAnna Hallander
Anna Hallander
MBMagnus Bruze
Magnus Bruze


27 April 2015 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
MIMarléne Isaksson
Marléne Isaksson
KRKristina Ryberg
Kristina Ryberg
AGAn Goossens
An Goossens
MBMagnus Bruze
Magnus Bruze

1 May 2015 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
MIMarléne Isaksson
Marléne Isaksson
SOS Olhardt
S Olhardt
JRJ Rådehed
J Rådehed
ÅSÅ Svensson
Å Svensson
Atopic dermatitis is the most common chronic inflammatory disease among children in industrialised countries. Many factors influence this di...

1 September 2004 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
MIMarléne Isaksson
Marléne Isaksson
Up to 5% of dermatitis patients are allergic to corticosteroids. Because such allergy may be difficult to suspect due to the anti-inflammatory action of the corticosteroid, markers for corticosteroid allergy should be present in any standard series. Budesonide and tixocortol pivalate are two such markers, and they seem to detect a majority of corticosteroid allergy. The patch test concentration for a given corticosteroid may be crucial. A false-negative reaction may follow despite the patient being allergic, if too high a test concentration is used, because of the anti-inflammatory action of the corticosteroid. Patch test readings must be performed not only on Day 3 or Day 4 but also on a late occasion, i.e., Day 7 after test application, also because the anti-inflammatory action may suppress an allergic reaction at an early reading. Once a patient has reacted to a corticosteroid, an extended corticosteroid series should be tested, so that information may be given on which corticosteroids to use and, above all, which corticosteroids to avoid.